论文信息 - Dasatinib in advanced HER2/neu amplified and ER/PR-positive breast cancer: Phase II study CA180088. - 字舞流文

Dasatinib in advanced HER2/neu amplified and ER/PR-positive breast cancer: Phase II study CA180088.

H. Rugo | J. Sparano | M. Campone | P. Fumoleau | A. Awada | J. Baurain | E. Mayer | O. Sy | A. Llombart | H. Rugo | J. Sparano | L. Strauss | Jean-François Baurain